Jeff Yass’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
Other funds holding NRXP
BGI
Jeff Yass's NRXP Position: Q3 2026 in Review
Jeff Yass opened a new position in NRX Pharmaceuticals (NRXP) in Q3 2026: 12,197 shares worth $35.6K. The stake represents ﹤0.01% of the portfolio and ranks #12995 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NRXP as recently as Q4 2024.
Jeff Yass first reported a position in NRXP in Q2 2019 and has held it in 11 quarters since. The position peaked at $513K in Q3 2021. 50 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.
- Jeff Yass held 12,197 shares of NRX Pharmaceuticals worth $35.6K as of Q3 2026.
- NRX Pharmaceuticals was a new Jeff Yass position in Q3 2026.
- NRX Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12995 holding.
- Jeff Yass first reported a position in NRX Pharmaceuticals in Q2 2019 and has held it in 11 quarters since.
- Jeff Yass's NRX Pharmaceuticals position peaked at $513K in Q3 2021.
- 50 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.